Market Research Study

  Onychomycosis Market Analysis , Revenue Forecast, Competitive Landscape, Growth Factors, and Trends: Information by Type (Distal Subungual Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungual Onychomycosis (PSO), Candida Onychomycosis and others), Treatment Type (Drug Treatment, Topical Therapy and others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) The Global Onychomycosis Market is expected to register a CAGR of 6.28% during the forecast period with a market value of USD 7,912.5 Million till 2025. Onychomycosis is a general term used to denote any fungal nail infection. Factors such as the surging diabetic patient population, rising per capita healthcare expenditure coupled with the rising occurrences of onychomycosis, are anticipated to fuel the growth of the global onychomycosis market. However, the lack of awareness about onychomy...

  The Global Cardiomyopathy Medication Market Share is anticipated to reach USD 620 Million by 2025 at a CAGR of ~4.60% during the forecast period. Cardiomyopathy is a disease that causes the thickening and enlargement of the heart muscles and abnormal blood flow. Patients suffering from cardiomyopathy showcase symptoms such as dizziness, coughing, fatigue, and swelling of the legs, ankles, and feet. Certain factors that propel the growth of the global cardiomyopathy medication market are the high patient pool of heart disease, focus on manufacturing medication for cardiomyopathy treatment, and rising healthcare expenditure.  Currently, the global cardiomyopathy medication market is dominated by several players. The major players in this market are involved in strategic acquisitions and product launches to expand their product portfolios. For instance, in May 2019, Pfizer Inc. received US FDA approval for Vyndamax (tafamidis) and Vyndaqel (tafamidis meglumine) for the t...

  According to MRFR analysis, the global  implantable cardioverter defibrillator market size is expected to register a CAGR of 5.96% during the forecast period. Implantable Cardioverter Defibrillator (ICD) is used to record the heart's activity and treat dangerous ventricular arrhythmias with an electrical shock or pulse to the heart. Factors such as the growing aging population, changing lifestyles such as smoking and alcohol consumption, and the increase in demand for cardiac implants are responsible for the increasing prevalence of cardiac arrhythmias globally. This is likely to fuel the growth of the ICD market during the forecast period. In addition to this, improving efficacy of ICDs for the treatment of cardiac diseases over a period will also fuel the market. According to the American Heart Association, approximately 1.5 million cases of myocardial infarction occur annually, and the incidence rate is approximately 600 cases per 100,000 people in the US. According...

  The global  telehealth market share  is growing pervasively mainly due to the range of advantages the telehealth it offers. Main five benefits of telehealth include improved outcomes, enhanced care-coordination that maximizes clinical efficiency driving consumer engagement, and all this at much-reduced costs. The uptake of Telehealth is on the rise as more users view telehealth as a viable alternative to traditional, in-person visits. As patients’ acceptance increases, the telehealth market will be evaluated in terms of value. Acknowledging the potential of the market to increase further, Market Research Future (MRFR) in its recently published study report asserts that the global telehealth market will perceive a splendid growth by 2023 registering a double-digit CAGR of 29.8% during the forecast. The patients' journey is unlikely to change since users of telehealth services will need to be seamlessly integrated into the familiar payer/provider constructs (access, re...

According to MRFR analysis, the global  musculoskeletal system disorders market share  is expected to register a CAGR of ~5.30% during the forecast period and was valued at USD 3837.7 million in 2018. Musculoskeletal system disorders affect movement or musculoskeletal systems such as muscles, tendons, and ligaments. These disorders are also known as repetitive motion injuries. Musculoskeletal system disorders can arise by making the same motion repeatedly or lifting heavy objects. They affect different parts of the body, mainly the upper and lower back and neck. The growth of global musculoskeletal system disorders market is driven by various factors such as an increasing global geriatric population, rising prevalence, and improper posture, and poor fitness levels. However, the high costs of surgery are expected to curb the growth of the global musculoskeletal system disorders market. The global musculoskeletal system disorders market is currently dominated by several ma...

  Hazmat Suits Market Trends , Research Report, Revenue Forecast, Competitive Landscape, Growth Factors: Information by Application (Infection Control & Biohazard, Chemical Waste, Haz-Mat and others), End Use (Oil & Gas, Healthcare, Manufacturing, Mining & Metallurgy, Construction, Utilities, Transportation and others), Safety Standards (Level A, Level B, Level C and others) and Regions (Americas, Europe, Asia-Pacific and the Middle East & Africa) The Global  Hazmat Suits Market  is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 6768.19 million in 2018 and is projected to register a CAGR of 5.9% over the forecast period. Hazmat suits are also known as chemical suits, biohazard suits, and anti-radiation suits. They are personal protective equipment which provides protection against chemical and biological hazards. The rising cases of Ebola are one of the key factors driving the hazmat...

  Orthokeratology Lens Market Forecast , Revenue, Competitive Landscape, Growth Factors, and Trends: Information by Material (Silicone Acrylate, Fluorosilicone Acrylate and Fluorocarbon Acrylate), Application (Myopia and Hyperopia), End User (Hospitals and Ophthalmic Clinic) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) The Global Orthokeratology Lens Market size is expected to register a CAGR of7.4% during the forecast period with a market value of USD 3,857.8 Million till 2025. Orthokeratology is also known as ortho-k, corneal refractive therapy (CRT), and overnight vision correction therapy. In the orthokeratology therapy, rigid gas permeable contact lenses are worn overnight that reshapes the curvature of the cornea to improve object visibility. The use of ortho-k lenses eliminates the need for daytime contact lenses or glasses and improves vision. The increasing advancements in the field of ophthalmology over the past couple of decades, low...

The global   hydrocephalus market   size is estimated to balloon to USD 1,752.07 million by 2023, asserts Market Research Future (MRFR). It can exhibit 4.4% CAGR over the forecast period. It was previously valued at USD 1,348 million in 2017. High incidence of traumatic brain injuries owing to accidents is the primary driver of the market. Increasing prevalence of traumatic brain injuries (TBI) caused by accidents is one of the major factors driving market growth. Posttraumatic hydrocephalus is a condition caused in the aftermath of BTI which can use blockage in ventricles of the brain leading to excess levels of cerebrospinal fluid (CSF). Investments in development of new shunts which can expedite the draining of CSF are likely to spur market growth. Emergence of various neurovascular diseases such as arteriovenous malformations (AVMs) and brain aneurysm is predicted to bolster the hydrocephalus market growth. This can be attributed to the uptick of neurological conditions wi...